Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1996
10/15/1996US5565193 Hair styling compositions containing a silicone grafted polymer and low level of a volatile hydrocarbon solvent
10/15/1996US5565189 Wound cleanser method of use
10/15/1996US5565188 Therapeutiac or diagnostic agents having polyoxyalkylene glycol triblock polymers adsorbed on particle surfaces
10/15/1996US5564458 Timing valve for the discontinuous metering of a volume flow
10/15/1996US5564345 Stackable table, table assembly, and tray and table combination
10/15/1996CA2042972C Treatment of ocular hypertension with a synergistic combination for ocular administration
10/12/1996CA2173821A1 Method for determining pharmacodynamic parameters and designing a dosing regimen for a drug
10/11/1996CA2148851A1 Atp-diphosphohydrolases and process of purification thereof
10/10/1996WO1996031551A1 Microgels
10/10/1996WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996WO1996031239A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
10/10/1996WO1996031236A1 Chlamydia vaccines
10/10/1996WO1996031231A1 Controlled release biodegradable nanoparticles containing insulin
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031223A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996WO1996031221A1 Preparation of sodium chloride aerosol formulations
10/10/1996WO1996031218A1 Pharmaceutical composition containing sucralfate
10/10/1996WO1996031216A1 A method of preventing colon cancer with vitamin d3 analogues
10/10/1996WO1996031215A1 Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
10/10/1996WO1996031213A1 Pharmaceutical composition containing proton pump inhibitors
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996WO1996031205A1 Compositions and process for treating uremic pruritus
10/10/1996WO1996031203A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/10/1996WO1996031202A1 Controlled release biodegradable micro- and nanospheres containing cyclosporin
10/10/1996WO1996031201A1 Rate-controlled transdermal administration of risperidone
10/10/1996WO1996031200A1 Transdermal system with electrodes as initialization system
10/10/1996WO1996031199A1 Pharmaceutical microencapsulation
10/10/1996WO1996031198A1 Controlled release insufflation carrier for medicaments
10/10/1996WO1996031197A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996WO1996031196A1 Novel compositions of lipids and stabilizing materials
10/10/1996WO1996031195A1 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
10/10/1996WO1996031194A2 Skin care compositions containing retinoids and liposomes
10/10/1996WO1996031126A1 New cellulosic materials for incorporation into food products and methods of making same
10/10/1996WO1996026890A3 Method of producing hydrophilic or partially hydrophilic inorganic aerogels
10/10/1996WO1996026718A3 Controlled release tablet
10/10/1996WO1996020735A3 Oral gastrointestinal x-ray contrast agents in combination with surfactants
10/10/1996CA2217701A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996CA2217360A1 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
10/10/1996CA2217233A1 Sucralfate containing pharmaceutical composition
10/10/1996CA2217201A1 Skin care compositions containing retinoids and liposomes
10/10/1996CA2217061A1 Transdermal system using electrodes as the initialising system
10/10/1996CA2216934A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996CA2216363A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/10/1996CA2216359A1 Pharmaceutical microencapsulation
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/10/1996CA2214420A1 Rate-controlled transdermal administration of risperidone
10/09/1996EP0736522A1 Ceramide compounds, process for their preparation and their use in cosmetics or dermatology
10/09/1996EP0736305A2 Ultrasound-enhanced delivery of material into and through the skin
10/09/1996EP0736303A2 Interferon solution
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736041A1 Transparent liquid for encapsulated drug delivery
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735898A1 Vaccines
10/09/1996EP0735896A1 Parathyroid hormone formulation
10/09/1996EP0735892A1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate
10/09/1996EP0735885A1 Psoriasis treatment
10/09/1996EP0735884A1 Flunisolide aerosol formulations
10/09/1996EP0735876A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
10/09/1996EP0735868A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
10/09/1996EP0735867A1 Transdermal delivery device containing an estrogen
10/09/1996EP0735866A1 Antimicrobial wipe compositions
10/09/1996EP0735865A1 Expulsion of material from a delivery device
10/09/1996EP0735864A1 Method for preparing low dose pharmaceutical products
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996EP0735862A1 Method for dry blend compression of medicaments
10/09/1996EP0735861A1 Tissue moisturizing and antimicrobial compositions
10/09/1996EP0735860A1 Novel foaming compositions, particularly for rectal foams, and resulting foams
10/09/1996EP0735854A1 Ethanol substitutes
10/09/1996EP0735853A1 W/o/w emulsions
10/09/1996EP0670718A4 Pulsatile particles drug delivery system.
10/09/1996EP0652741B1 Cosmetic or dermatological compositions, particularly shampoos which may be diluted in water without losing viscosity after dilution
10/09/1996EP0648116B1 Composition for controlled release of an active substance and method for the preparation of such a composition
10/09/1996EP0637236B1 Pharmaceutical preparation and process for its manufacture
10/09/1996EP0630287B1 Microcapsules with primary alcohol functions containing polysaccharide walls and compositions containing them
10/09/1996EP0557489B1 Composition providing a lasting cosmetic and/or pharmaceutical treatment of the upper epidermal layers by topical application on the skin
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1133012A Pharmaceutical formulations of nerve growth factor
10/09/1996CN1133006A Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple
10/09/1996CN1133005A Stabilized tablet formulation
10/09/1996CN1133004A Process for conditioning substances
10/09/1996CN1132758A High-molecular microglobe and its prepn and use
10/09/1996CN1132646A Oyster-spirulina capsule and its prepn process
10/09/1996CN1132644A Snuff for preventing and curing cold
10/09/1996CN1132641A Chinese medicine 'luoliping' for curing scrofula
10/09/1996CN1132632A Health oral liquid for curing thrombus
10/09/1996CN1132629A Efficient hepatitis-curing concentrated liquid
10/09/1996CN1132628A Immunizing health oral liquid
10/09/1996CN1132627A Chinese medicinal eyedrops
10/09/1996CN1132626A Improved calcium dietary supplement
10/08/1996US5563258 Sucralfate aqueous suspension and its method of preparation
10/08/1996US5563191 Phase-separated membrane
10/08/1996US5563177 Taste masking guaifenesin containing liquids
10/08/1996US5563163 Treatment of degenerative diseases
10/08/1996US5563134 Pharmaceutical compositions comprising clozapine and a radical scavenger
10/08/1996US5563122 Stabilized parathyroid hormone composition
10/08/1996US5563056 Forming a matrix having first chemical species covalently immobilized and includes free molecules of second chemical species, gradually releasing the second species molecule from matrix
10/08/1996US5562924 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same
10/08/1996US5562923 Micronized pharmaceutically inhalable substances
10/08/1996US5562921 Stable solid pharmaceutical compositions containing enalapril maleate